Research and trials

Professor Jody Rosenblatt tells us why dysregulated cell death could have an impact not only on metastasis, but also therapy resistance.

There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test.

Find out how the OPTIMAM project’s mammogram collection is heralding a new dawn of machine learning based cancer detection

Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.

Find out how the chemistry inside plants can lead to life-changing drugs and how a cannabis-derived drug is part of a new trial to help people with a type of aggressive brain cancer.

Right now there isn’t enough reliable evidence to prove that any form of cannabis can effectively treat cancer in patients.

The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.

Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research

The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.

Explore three of the latest companies to come out of one of our entrepreneurial programmes.